EGS receives $30.5M to advance minimally invasive GERD Technique
EndoGastric Solutions has raised $30.5 million to commercialize its minimally invasive procedure aimed at patients with gastroesophageal reflux
EndoGastric Solutions gets $50M for “natural orifice” device to treat GERD
EndoGastric Solutions' well funded TIF procedure is meant to improve acid reflux issues in those with serious GERD.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
EndoGastric Solutions raising $25M for “natural orifice” devices to treat GERD
EndoGastric Solutions has raised more than $160 million for its device that one-ups laparoscopy - it helps surgeons conduct stomach surgery through the mouth, so no incisions need to be made.